PRKN and neoplasm: However, a recent Ub screen carried out in the absence of harsh and potentially nonphysiologic mitochondria-depolarizing conditions (25) suggested a different scenario and identified Parkin as a potent inhibitor of mitochondria-fueled tumor cell movements (26).